Effects of irbesartan on the expression of matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 in streptozotocin-induced diabetic rat kidney

Chin Med J (Engl). 2005 Jun 20;118(12):1040-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / pharmacology*
  • Animals
  • Biphenyl Compounds / pharmacology*
  • Creatinine / metabolism
  • Diabetes Mellitus, Experimental / metabolism*
  • Diabetes Mellitus, Experimental / pathology
  • Hypertrophy
  • Immunohistochemistry
  • Irbesartan
  • Kidney / metabolism*
  • Kidney / pathology
  • Male
  • Matrix Metalloproteinase 2 / analysis*
  • Matrix Metalloproteinase 2 / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Streptozocin
  • Tetrazoles / pharmacology*
  • Tissue Inhibitor of Metalloproteinase-2 / analysis*
  • Tissue Inhibitor of Metalloproteinase-2 / genetics

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Biphenyl Compounds
  • Tetrazoles
  • Tissue Inhibitor of Metalloproteinase-2
  • Streptozocin
  • Creatinine
  • Matrix Metalloproteinase 2
  • Irbesartan